These findings highlight the essential role of the ChREBP‐controlled SCAMP5 in β‐cell insulin secretion and apoptosis, revealing a previously unrecognized mechanism underlying the β‐cell failure in diabetes. Here, MLXIPL is linked to diabetes mellitus.